Previous Article | Next Article 
Journal of Clinical Microbiology, January 2007, p. 109-111, Vol. 45, No. 1
0095-1137/07/$08.00+0 doi:10.1128/JCM.01969-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Statistical Analyses of Correlation between Fluconazole MICs for Candida spp. Assessed by Standard Methods Set Forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2)
Juan Luis Rodriguez-Tudela,1*
J. Peter Donnelly,2
Michael A. Pfaller,3
Erja Chryssantou,4
Peter Warn,5
David W. Denning,6
Ana Espinel-Ingroff,7
Francesco Barchiesi,8 and
Manuel Cuenca-Estrella1
Servicio de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain,1
Department of Haematology, Radboud University Nijmegen Medical Centre and Nijmegen University Centre for Infectious Diseases, Radboud University, Nijmegen, The Netherlands,2
Department of Pathology, University of Iowa College of Medicine, Iowa City, Iowa,3
Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden,4
School of Medicine, University of Manchester, Stopford Building, Oxford Road, Manchester, United Kingdom,5
Education and Research Centre, Wythenshawe Hospital, Southmoor Road, Manchester, United Kingdom,6
VCU Medical Center, 1101 E. Marshall St., Sanger Hall, Rm. 7-049, P.O. Box 980049, Richmond, Virginia,7
Istituto di Malattie Infettive e Medicina Pubblica, Università Politecnica delle Marche, Ancona, Italy8
Received 22 September 2006/
Returned for modification 17 October 2006/
Accepted 25 October 2006

ABSTRACT
The European Committee on Antimicrobial Susceptibility Testing
(EUCAST) Subcommittee on Antifungal Susceptibility Testing recently
published a standard for determining the susceptibility of fermentative
yeasts to antifungals. From the beginning, the EUCAST and its
North American counterpart, the CLSI, decided to work together
in order to establish common standards. As part of this exercise,
the susceptibility of a set of 475 yeast isolates was tested
by both standards. The intraclass correlation coefficient and
the equations defining the linear regression between both methods
were estimated. Both methods produced very similar results,
with an intraclass correlation coefficient of 0.954 (0.945 to
0.962), although linear regression analysis shows that the EUCAST
standard resulted in slightly lower MICs. There were only eight
isolates showing at least four twofold dilution MIC differences
between both standards. After 24 h of incubation, the MICs obtained
by the CLSI method were equivalent to those obtained by the
EUCAST standard. In summary, both methods produce very similar
MICs, indicating that methodology does not pose any obstacle
to obtaining uniform standards for antifungal susceptibility
testing of yeasts.

INTRODUCTION
The Subcommittee on Antifungal Susceptibility Testing (AFST)
of the European Committee on Antimicrobial Susceptibility Testing
(EUCAST) has published a standard for the determination of antifungal
susceptibility testing of fermentative yeasts (
7). Hitherto,
only the M27-A2 reference method for broth dilution antifungal
susceptibility testing of yeasts issued by the CLSI (formerly
NCCLS) was available (
4). Besides being established to devise
a standard European methodology for antifungal susceptibility
testing, determine breakpoints for antifungal drugs, and establish
expert rules for interpreting these antimicrobial susceptibility
tests, the AFST also set out to produce results concordant with
those obtained using the CLSI method. Moreover, the EUCAST and
CLSI opted to work together with the aim of establishing common
standards.
The standards of the EUCAST AFST and CLSI for determining the MICs of yeasts to antifungal drugs differ in several important respects (Table 1) and might be expected to result in major differences between the MICs generated using each method for the same strains. To investigate this, a series of Candida species were tested by both methods to determine the relationship between the MICs obtained and to identify any discrepancies that might have occurred.

MATERIALS AND METHODS
Microorganisms.
A set of 475 distinct clinical isolates containing 149 isolates
of
Candida albicans, 86 of
Candida glabrata, 73 of
Candida krusei,
87 of
Candida parapsilosis, and 80 of
Candida tropicalis was
selected.
Antifungal susceptibility testing.
The methods described in CLSI M27-A2 (4) and EUCAST E.Dis. 7.1 (7) were followed strictly for testing the susceptibility to fluconazole. Strains were tested once by both methods at the same time. Candida krusei ATCC 6258 and C. parapsilosis ATCC 22019 were included for quality control. MICs were read at 24 h for the EUCAST AFST method and at 48 h for the CLSI M27-A2 method.
Statistical analysis.
Statistical analysis was done using SPSS, version 13.0 (SPSS, S.L. Madrid, Spain).
MIC values were transformed to log2. Linear regression analysis for both methods was done to test the linearity of the relationship between the CLSI M27-A2 and EUCAST AFST MICs. A two-way random effect model was utilized to calculate the intraclass correlation coefficient (ICC) with a confidence interval of 95% using the following equation: ICC = (group mean square error mean square)/(group mean square + error mean square) (3). The ICC has a maximum value of 1 if there is a perfect correlation and a minimum value of 1 if there is a complete absence of correlation.
A difference of at least four twofold dilutions was considered a major discrepancy between the EUCAST AFST and CLSI M27-A2 methods.

RESULTS
The set of 475 strains was used for defining the mathematical
equivalencies between the EUCAST and CLSI methods. The regression
line between MICs obtained by each method showed that the MICs
were generally equivalent (Fig.
1). Mean MICs generated by both
methods were equivalent up to a mean MIC of 2 mg/liter (Table
2), but thereafter, MICs generated by the CLSI M27-A2 method
were twofold higher than those generated by the EUCAST AFST
method.
There were eight isolates that showed a major discrepancy (Table
3). Four isolates of
C. tropicalis and one isolate of
C. albicans exhibited high MICs by the CLSI M27-A2 method and low MICs by
the EUCAST AFST method. However, the MICs obtained by the CLSI
M27-A2 method at 24 h were within the range of those obtained
by the EUCAST M27-A2 method. The remaining three
C. albicans isolates with discrepant MICs exhibited high MICs by the EUCAST
AFST method and low MICs by the CLSI M27-A2 method.
ICCs were above 0.83 in every case (Table
4). The overall ICC
was 0.954 (95% confidence interval, 0.945 to 0.962). The slope
and intercept values indicate that the CLSI M27-A2 method results
in slightly higher MICs than the EUCAST AFST method.
View this table:
[in this window]
[in a new window]
|
TABLE 4. ICCs and 95% confidence intervals for fluconazole MICs obtained by the EUCAST E.Dis 7.1 and CLSI M27-A2 methods
|

DISCUSSION
The results of this study showed there were few major differences
between the MICs resulting from the CLSI M27-A2 and EUCAST AFST
methods. Not only did the regression analysis indicate close
proximity of the MICs generated by each method but the ICCs
confirmed this. Moreover, the relationship held true for values
of up to 2 mg/liter. Thereafter, mean MICs generated by the
CLSI M27-A2 method were twice those resulting from the EUCAST
AFST method. Major discrepancies were found only for 8 isolates
(1.6%) of the 475 tested.
These results were not expected given the differences between the two methods in terms of inoculum, incubation time, and concentration of glucose in the medium. The simplest explanation may well be that the extra glucose and higher inoculum allow sufficient growth for reading the MICs after 24 h rather than having to wait an extra 24 h (8). Besides assuming that a final density of 108 CFU/ml is needed for visible growth, that a lag period of 4 h occurs in the medium, and that a generation time of 120 min is achieved under these conditions, the EUCAST AFST method with the 100-fold-higher inoculum would patently reach this threshold well ahead of the CLSI M27-A2 method. It has previously been documented that a higher inoculum size significantly shortened the length of the lag phase and that the supplementation of glucose increased the growth of Candida spp. Thus, this medium-inoculum combination shortened the lag phase and yielded elevated optical densities after 24 h (2). Whatever the explanation, these results are encouraging as they suggest that there is no major difference between the two methods except that the EUCAST AFST method is quicker. Moreover, it would appear that the MICs generated by either method are equivalent up to 2 mg/liter, that is, within the susceptibility range for clinical success. That MICs of 4 mg/liter and higher generated by the CLSI M27-A2 method tend to be twofold higher than those obtained with the EUCAST AFST method may not pose any real difficulties since this difference is within the acceptable range.
Of the eight isolates showing significantly discrepant MICs, five showed high MICs with the CLSI M27-A2 method and low MICs with the EUCAST AFST method. Fortunately, the results of MICs obtained after 24 h with the CLSI M27-A2 method were concordant with those generated with the EUCAST AFST method. Two investigations of a murine model of invasive candidosis of several isolates with low MICs at 24 h and high MICs at 48 h (1, 6) concluded that the MICs read at 24 h for a 50% reduction in growth correlated with the in vivo response, i.e., under conditions adopted by the EUCAST AFST method (7). In addition, Revankar et al. showed that oropharyngeal candidosis caused by strains susceptible at 24 h and resistant at 48 h (significant trailing growth) responded to doses of fluconazole as low as 100 mg/day (5).
In summary, the CLSI M27-A2 and EUCAST AFST standards for yeasts result in essentially equivalent MICs. This would suggest that the method for determining the MICs will not account for any differences that might be found between the breakpoints set by the CLSI and those eventually adopted by the EUCAST AFST.

FOOTNOTES
* Corresponding author. Mailing address: Servicio de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Ctra. Majadahonda Pozuelo km 2, 28220 Majadahonda, Madrid, Spain. Phone: 34 91 822 3919. Fax: 34 91 509 7966. E-mail:
juanl.rodriguez-tudela{at}isciii.es.

Published ahead of print on 8 November 2006. 

REFERENCES
1 - Arthington-Skaggs, B. A., D. W. Warnock, and C. J. Morrison. 2000. Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis. Antimicrob. Agents Chemother. 44:2081-2085.[Abstract/Free Full Text]
2 - Cuenca-Estrella, M., T. M. Diaz-Guerra, E. Mellado, and J. L. Rodriguez-Tudela. 2001. Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp. J. Clin. Microbiol. 39:525-532.[Abstract/Free Full Text]
3 - McGraw, K. O., and S. P. Wong. 1996. Forming inferences about some intraclass correlation coefficients. Psychol. Methods 1:30-46.[CrossRef]
4 - National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
5 - Revankar, S. G., W. R. Kirkpatrick, R. K. McAtee, A. W. Fothergill, S. W. Redding, M. G. Rinaldi, and T. F. Patterson. 1998. Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method. J. Clin. Microbiol. 36:153-156.[Abstract/Free Full Text]
6 - Rex, J. H., P. W. Nelson, V. L. Paetznick, M. Lozano-Chiu, A. Espinel-Ingroff, and E. J. Anaissie. 1998. Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis. Antimicrob. Agents Chemother. 42:129-134.[Abstract/Free Full Text]
7 - Rodriguez-Tudela, J. L., F. Barchiesi, J. Bille, E. Chryssanthou, M. Cuenca-Estrella, D. Denning, J. P. Donnelly, B. Dupont, W. Fegeler, C. Moore, M. Richardson, P. E. Verweij, and the Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). 2003. Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts. Clin. Microbiol. Infect. 9:I-VIII.[CrossRef]
8 - Rodriguez-Tudela, J. L., and J. V. Martinez-Suarez. 1994. Improved medium for fluconazole susceptibility testing of Candida albicans. Antimicrob. Agents Chemother. 38:45-48.[Abstract/Free Full Text]
Journal of Clinical Microbiology, January 2007, p. 109-111, Vol. 45, No. 1
0095-1137/07/$08.00+0 doi:10.1128/JCM.01969-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Antonopoulou, S., Aoun, M., Alexopoulos, E. C., Baka, S., Logothetis, E., Kalambokas, T., Zannos, A., Papadias, K., Grigoriou, O., Kouskouni, E., Velegraki, A.
(2009). Fenticonazole Activity Measured by the Methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida Vulvovaginitis Isolates from Two European Regions and Annotations on the Prevalent Genotypes. Antimicrob. Agents Chemother.
53: 2181-2184
[Abstract]
[Full Text]
-
Dimopoulos, G., Velegraki, A., Falagas, M. E.
(2009). A 10-Year Survey of Antifungal Susceptibility of Candidemia Isolates from Intensive Care Unit Patients in Greece. Antimicrob. Agents Chemother.
53: 1242-1244
[Abstract]
[Full Text]
-
Pfaller, M. A., Boyken, L. B., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S., Diekema, D. J.
(2008). Validation of 24-Hour Fluconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Results from a Global Candida Antifungal Surveillance Program. J. Clin. Microbiol.
46: 3585-3590
[Abstract]
[Full Text]
-
Ostrosky-Zeichner, L., Rex, J. H., Pfaller, M. A., Diekema, D. J., Alexander, B. D., Andes, D., Brown, S. D., Chaturvedi, V., Ghannoum, M. A., Knapp, C. C., Sheehan, D. J., Walsh, T. J.
(2008). Rationale for Reading Fluconazole MICs at 24 Hours Rather than 48 Hours When Testing Candida spp. by the CLSI M27-A2 Standard Method. Antimicrob. Agents Chemother.
52: 4175-4177
[Abstract]
[Full Text]
-
Cuenca-Estrella, M., Gomez-Lopez, A., Gutierrez, M. O., Buitrago, M. J., Rodriguez-Tudela, J. L.
(2008). Reliability of the WIDERYST Susceptibility Testing System for Detection of In Vitro Antifungal Resistance in Yeasts. Antimicrob. Agents Chemother.
52: 1062-1065
[Abstract]
[Full Text]
-
Rodriguez-Tudela, J. L., Almirante, B., Rodriguez-Pardo, D., Laguna, F., Donnelly, J. P., Mouton, J. W., Pahissa, A., Cuenca-Estrella, M.
(2007). Correlation of the MIC and Dose/MIC Ratio of Fluconazole to the Therapeutic Response of Patients with Mucosal Candidiasis and Candidemia. Antimicrob. Agents Chemother.
51: 3599-3604
[Abstract]
[Full Text]